Recombinant Human Anti-PDGFR2 x Human Anti-VEGFR2 Bispecific Antibody (scIgG) (SCIGG-H350)

Recombinant Anti-PDGFR2 x Anti-VEGFR2 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-PDGFR2 and anti-VEGFR2 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can block two receptors simultaneously. It is designed for the research of Cancers therapy.

Datasheet INQUIRY

Specifications

Targets

PDGFR2 & VEGFR2

Type

Single chain IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Cancers

Targets

Target 1

PDGFR2

Gene ID

5156

UniProt ID

P16234

Alternative Names

PDGFRA; PDGFR2; platelet derived growth factor receptor, alpha polypeptide; CD140a; Pdgfr-2; AI115593; platelet-derived growth factor receptor alpha; PDGFR-alpha; PDGF-R-alpha; PDGF alpha chain; CD140 antigen-like family member A; platelet-derived growth factor alpha receptor; alpha-type platelet-derived growth factor receptor; Alpha platelet-derived growth factor receptor precursor (PDGF-R-alpha)

Target 2

VEGFR2

Gene ID

3791

UniProt ID

A0A024RD88

Alternative Names

FLK1; CD309; VEGFR; VEGFR2; Vascular endothelial growth factor receptor 2; Kinase insert domain receptor; Fetal liver kinase 1; Kinase insert domain receptor, a type III receptor; KDR

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-PDGFR2 x Human Anti-VEGFR2 Bispecific Antibody (scIgG) (SCIGG-H350). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-PDGFR2 x Human Anti-VEGFR2 Bispecific Antibody (scIgG) (CAT#: SCIGG-H350)

Specifications

Targets

Customer Reviews and Q&As